Francesca Ceccherini‐Silberstein

Author

Also Known As

A Castagna, A. Castagna, Adriano Lazzarin, Antinori, A, Ceccherini-Silberstein, F, Ceccherini-Silberstein, Francesca, F Ceccherini Silberstein, F Ceccherini-Silberstein, F Ceccherini‐Silberstein, F. Ceccherini Silberstein

514

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani University of Milan Istituti di Ricovero e Cura a Carattere Scientifico University of Modena and Reggio Emilia

About

Francesca Ceccherini‐Silberstein is an author at University of Rome Tor Vergata specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	44	1.8K
2	Public Health	8	8	387
3	Natural Sciences	5	5	243
4	Biochemistry	2	2	90
5	Engineering	1	1	12

Francesca Ceccherini‐Silberstein

161

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
2025 update of the drug resistance mutations in HIV-1. Annemarie M. J. Wensing, Vincent Cálvez, Francesca Ceccherini‐Silberstein, PubMed Regimen SimplificationImmunologyQuantitative PharmacologyPharmacotherapyAntiviral Drug	2005	217
Characterization and structural analysis of HIV-1 integrase conservation. Francesca Ceccherini‐Silberstein, Isabelle Malet, Roberta D’Arrigo, PubMed Hiv-1 Integrase ConservationHiv-1 IntegraseHuman RetrovirusPathogenesisImmunology	2009	145
European recommendations for the clinical use of HIV drug resistance testing: 2011 update. Anne–Mieke Vandamme, Ricardo Camacho, Francesca Ceccherini‐Silberstein, PubMed ImmunologyPharmacotherapyResistance TestingClinical UseHiv Resistance Tests	2011	145
2019 update of the drug resistance mutations in HIV-1. Annemarie M. J. Wensing, Vincent Cálvez, Francesca Ceccherini‐Silberstein, PubMed	2019	142
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing Alessandro Cozzi‐Lepri, Marc Noguera-Julián, Francesca Di Giallonardo, Journal of Antimicrobial Chemotherapy	2014	122
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation Federica Laudisi, Davide Di Fusco, Vincenzo Dinallo, Cellular and Molecular Gastroenterology and Hepatology	2018	114
Functional characterization of substance P receptors on cultured human spinal cord astrocytes: Synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production Carla Palma, Luisa Minghetti, Mara Astolfi, Glia	1997	93
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection Valentina Svicher, Valeria Cento, Martina Bernassola, Antiviral Research Diagnostic VirologyViral PersistenceViral DiagnosticsViral HepatitisImmunology	2011	90
Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies Velia Chiara Di Maio, Valeria Cento, Ilaria Lenci, Liver International	2017	89
HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors Valeria Cento, Carmen Mirabelli, Romina Salpini, PLoS ONE	2012	88

Page 1